Al-Dawaa Medical Services Company (TADAWUL:4163)
Saudi Arabia · Delayed Price · Currency is SAR 38.30
-0.06 (-0.16%)
Sep 3, 2026, 3:18 PM AST
TADAWUL:4163 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,256 | 4,242 | 6,664 | 8,993 | 6,112 | - | |
Market Cap Growth | -40.48% | -36.35% | -25.90% | 47.15% | - | - |
Enterprise Value | 5,542 | 6,338 | 8,707 | 11,237 | 9,020 | - |
Last Close Price | 38.30 | 47.94 | 72.69 | 95.61 | 63.05 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.84 | 13.18 | 18.96 | 27.32 | 20.01 | - |
Forward PE | 16.26 | 11.05 | 16.26 | 22.12 | 30.16 | - |
PS Ratio | 0.50 | 0.63 | 1.03 | 1.57 | 1.14 | - |
PB Ratio | 2.41 | 2.92 | 5.01 | 6.85 | 5.58 | - |
P/TBV Ratio | 2.45 | 2.96 | 5.09 | 6.96 | 5.68 | - |
P/FCF Ratio | 8.96 | 8.28 | 14.48 | 17.67 | 11.47 | - |
P/OCF Ratio | 6.43 | 6.43 | 9.64 | 12.39 | 7.86 | - |
PEG Ratio | - | 1.13 | 1.19 | 1.36 | 1.23 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.84 | 0.94 | 1.35 | 1.96 | 1.68 | - |
EV/EBITDA Ratio | 7.59 | 9.99 | 13.30 | 17.98 | 17.33 | - |
EV/EBIT Ratio | 17.86 | 14.11 | 17.75 | 23.96 | 24.48 | - |
EV/FCF Ratio | 15.26 | 12.37 | 18.92 | 22.08 | 16.92 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.77 | 1.58 | 1.58 | 1.75 | 2.40 | 2.27 |
Debt / EBITDA Ratio | 3.24 | 2.66 | 2.42 | 2.77 | 3.67 | 3.76 |
Debt / FCF Ratio | 6.58 | 4.47 | 4.56 | 4.51 | 4.94 | 6.10 |
Net Debt / Equity Ratio | 1.70 | 1.53 | 1.54 | 1.71 | 2.28 | 2.22 |
Net Debt / EBITDA Ratio | 4.52 | 3.49 | 3.13 | 3.58 | 4.79 | 5.30 |
Net Debt / FCF Ratio | 6.30 | 4.33 | 4.46 | 4.40 | 4.68 | 5.98 |
Asset Turnover | 1.22 | 1.31 | 1.32 | 1.25 | 1.26 | 1.33 |
Inventory Turnover | 2.53 | 2.66 | 2.91 | 3.04 | 2.82 | 2.39 |
Quick Ratio | 0.36 | 0.32 | 0.37 | 0.29 | 0.29 | 0.15 |
Current Ratio | 1.20 | 1.21 | 1.12 | 1.12 | 1.10 | 0.89 |
Return on Equity (ROE) | 12.68% | 23.14% | 26.59% | 27.34% | 29.31% | 22.75% |
Return on Assets (ROA) | 3.69% | 5.44% | 6.26% | 6.37% | 5.40% | 4.36% |
Return on Invested Capital (ROIC) | 8.37% | 12.36% | 13.31% | 12.63% | 10.45% | 8.52% |
Return on Capital Employed (ROCE) | 10.20% | 14.00% | 17.20% | 16.10% | 12.80% | 13.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.61% | 7.59% | 5.27% | 3.66% | 5.00% | - |
FCF Yield | 11.16% | 12.07% | 6.91% | 5.66% | 8.72% | - |
Dividend Yield | 6.58% | 5.26% | 3.46% | 2.61% | 3.96% | - |
Payout Ratio | 117.35% | 66.38% | 60.58% | 64.67% | 34.65% | 146.91% |
Total Shareholder Return | 6.58% | 5.26% | 3.46% | 2.61% | 3.96% | - |